GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (FRA:EWL) » Definitions » Total Liabilities

Edwards Lifesciences (FRA:EWL) Total Liabilities : €2,346 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Edwards Lifesciences Total Liabilities?

Edwards Lifesciences's Total Liabilities for the quarter that ended in Mar. 2024 was €2,346 Mil.

Edwards Lifesciences's quarterly Total Liabilities declined from Sep. 2023 (€2,477.15 Mil) to Dec. 2023 (€2,424.37 Mil) and declined from Dec. 2023 (€2,424.37 Mil) to Mar. 2024 (€2,345.91 Mil).

Edwards Lifesciences's annual Total Liabilities declined from Dec. 2021 (€2,360.03 Mil) to Dec. 2022 (€2,346.60 Mil) but then increased from Dec. 2022 (€2,346.60 Mil) to Dec. 2023 (€2,424.37 Mil).

Edwards Lifesciences Total Liabilities Historical Data

The historical data trend for Edwards Lifesciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Total Liabilities Chart

Edwards Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,105.82 2,188.82 2,360.03 2,346.60 2,424.37

Edwards Lifesciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,418.31 2,360.57 2,477.15 2,424.37 2,345.91

Edwards Lifesciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Edwards Lifesciences's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1096.182+(614.39+713.793
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=2,424

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=8586.054-6161.69
=2,424

Edwards Lifesciences's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1021.936+(620.448+703.524
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=2,346

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=8957.396-6611.488
=2,346

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edwards Lifesciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Edwards Lifesciences (FRA:EWL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (FRA:EWL) » Definitions » Total Liabilities
Comparable Companies
DXCM ZBH ALGN STE SWAV BRKR PODD PEN BIO MASI ABT SYK BSX MDT XTER:SHL SZSE:300760 XAMS:PHIA XSWX:SOON SHSE:688271 ASX:COH
Traded in Other Exchanges
EW:USA EW:Mexico 1EW:Italy EWL:Germany E1WL34:Brazil EWLS:Austria
Address
One Edwards Way, Irvine, CA, USA, 92614
Website
https://www.edwards.com
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.